# CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas

> **NCT02981862** · NA · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 100 (actual)

## Conditions studied

- Cervical Cancer
- Vulvar Cancer
- Anal Cancer
- Oropharynx Cancer
- Oral Cavity Cancer
- Penis Cancer

## Interventions

- **OTHER:** CaptHPV method

## Key facts

- **NCT ID:** NCT02981862
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-19
- **Primary completion:** 2018-06-12
- **Final completion:** 2018-06-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981862, "CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02981862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*